Daniel Neumann
Pediatrics · Roy, UTNPI 1609258433
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,887 of the $4,201 with a category attached, or 68.7%. 21 manufacturers reported payments, led by AstraZeneca at 39.5% of the total. Reporting peaked in 2019 at $1,955 and has fallen 76.0% since, to $469 in 2025. Among pediatrics clinicians in UT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 118 payments — averaging $35.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- Tris Pharma Inc$427
- Supernus Pharmaceuticals, Inc.$363
- Corium, LLC$264
- GSK$234
- Ironshore Pharmaceuticals Inc.$200
- plus $1K from 15 others
Across 121 payments — averaging $7841.42 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- GSK$335K
- Pfizer$227K
- Sanofi Pasteur Inc.$198K
- Sanofi US Services Inc.$189K
What the payments were for
- Travel & lodging$1,31431%
- Food & beverage$2,88769%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 11 | $1,661 |
| Tris Pharma Inc | 11 | $427 |
| Supernus Pharmaceuticals, Inc. | 6 | $363 |
| Corium, LLC | 15 | $264 |
| GSK | 12 | $234 |
| Ironshore Pharmaceuticals Inc. | 10 | $200 |
| Merck | 7 | $177 |
| Pfizer | 10 | $161 |
| Sanofi Pasteur Inc. | 3 | $153 |
| Cranial Technologies, Inc | 7 | $131 |
| Sobi, Inc | 6 | $116 |
| Shire North American Group Inc | 4 | $66 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $62 |
| Collegium Pharmaceutical, Inc. | 3 | $54 |
| Acadia Pharmaceuticals Inc | 1 | $31 |
| Adlon Therapeutics L.p. | 2 | $27 |
| Sanofi-aventis U.S. LLC | 1 | $18 |
| Seqirus USA Inc | 1 | $16 |
| Ultragenyx Pharmaceutical Inc. | 1 | $14 |
| Neurelis, Inc. | 1 | $14 |
| Arbor Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- QELBREE$293
- Dyanavel XR$243
- BEXSERO$122
How this compares
$4,201 in reported general payments places this provider in the 95th percentile of 439 pediatrics providers in Utah.
Other pediatrics in Roy
- John AllredRoy$2K
- David NuttallAmerican Fork$307K
- Mari LuceLayton$289K
- Brian ShayotaSalt Lake City$93K
- Rodney PollaryLehi$56K
- Laura SavageProvo$49K
- Ashley AndrewsSalt Lake City$31K
- Samantha BostromClinton$18K
- Michael JensenSalt Lake City$18K
- Mary TiptonWest Jordan$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.